Vital Signs - 19 June 2006


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This issue of Vital Signs, released on June 19, 2006, provides a strategic overview of the potential impact of CAD (computer aided detection) in the area of diagnostic medicine, including clinical benefits and drawbacks that could result from the use of computerized diagnostics. Additionally, an emerging company profile is provided on R2 Technologies, a perennial market leader in the CAD industry. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of June 5 - June 9, 2006.

Table of Contents

Vital Signs - 19 June 2006The New Wave in Diagnostic Medicine - Computer Aided Detection (CAD)The New Wave in Diagnostic Medicine - Computer Aided Detection (CAD)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.